At GLHR Investing, we’re dissecting the U.S. stock market’s performance over the first 18 days of June...
GLHR TEAM
At GLHR Investing, we’re dissecting the impact of President Trump’s 2025 tariffs on the steel, technology, and...
At GLHR Investing, we’re examining Pfizer’s 2024 financials—$58 billion in revenue, $10 billion in R&D, and $70...
At GLHR Investing, we’re diving into China’s e-commerce giants, Alibaba and JD.com, to assess whether their 2025...
At GLHR Investing, we’re equipping you with strategies to build a robust stock portfolio in 2025’s volatile...
At GLHR Investing, we’re spotlighting the top 10 stocks that have surged in value year-to-date (YTD) in...
At GLHR Investing, we’re zooming in on the U.S. Federal Reserve’s interest rate policy in 2025, a...
At GLHR Investing, we’re diving into the artificial intelligence (AI) market, a $235 billion juggernaut in 2024...
At GLHR Investing, we’re diving into the U.S. economy’s rollercoaster ride through the first half of 2025,...
At GLHR Investing, we’re dissecting the U.S. stock market’s performance during the first week of June 2025,...
